An investigation of cortical thickness and antidepressant response in major depressive disorder: A CAN-BIND study report-Reference-Cited by-同舟云学术

An investigation of cortical thickness and antidepressant response in major depressive disorder: A CAN-BIND study report

Published:2020 Issue: Volume:25 Page:102178
ISSN:2213-1582
Container-title:NeuroImage: Clinical
language:en
Short-container-title:NeuroImage: Clinical

Author:

Suh Jee Su^ORCID,Minuzzi Luciano,Raamana Pradeep Reddy^ORCID,Davis Andrew,Hall Geoffrey B.^ORCID,Harris Jacqueline,Hassel Stefanie^ORCID,Zamyadi Mojdeh,Arnott Stephen R.,Alders Gésine L.,Sassi Roberto B.^ORCID,Milev Roumen^ORCID,Lam Raymond W.,MacQueen Glenda M.,Strother Stephen C.^ORCID,Kennedy Sidney H.,Frey Benicio N.^ORCID

Funder

Canadian Institutes of Health Research

Publisher

Elsevier BV

Subject

Cognitive Neuroscience,Neurology (clinical),Neurology,Radiology, Nuclear Medicine and imaging

Reference69 articles.

1. Pretreatment and early-treatment cortical thickness is associated with SSRI treatment response in major depressive disorder;Bartlett;Neuropsychopharmacology,2018

2. The escitalopram versus electric current therapy for treating depression clinical study (ELECT-TDCS): rationale and study design of a non-inferiority, triple-arm, placebo-controlled clinical trial;Brunoni;Sao Paulo Med. J.,2015

3. Power failure: why small sample size undermines the reliability of neuroscience;Button;Nat. Rev. Neurosci.,2013

4. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis;Cipriani;Lancet North Am. Ed.,2018

5. A comparison of voxel and surface based cortical thickness estimation methods;Clarkson;Neuroimage,2011

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Shared genetic architecture of cortical thickness alterations in major depressive disorder and schizophrenia;Progress in Neuro-Psychopharmacology and Biological Psychiatry;2024-12

2. The effect of antidepressant treatment on blood BDNF levels in depressed patients: A review and methodological recommendations for assessment of BDNF in blood;European Neuropsychopharmacology;2024-10

3. Progress in Biomarkers to Improve Treatment Outcomes in Major Depressive Disorder;Clinical Textbook of Mood Disorders;2024-05-30

4. Gray matter biomarkers for major depressive disorder and manic disorder using logistic regression;Journal of Psychiatric Research;2024-03

5. A systematic review of abnormalities in intracortical myelin across psychiatric illnesses;Journal of Affective Disorders Reports;2024-01